Eiko Lifesciences inks pact to acquire 25.01% stake in Reflux Pharmaceuticals

18 May 2023 Evaluate

Eiko Lifesciences has entered into a Share Subscription Agreement (SSA) with Reflux Pharmaceuticals (RPPL) in connection with the acquisition of up to 19,20,000 Equity Shares being 25.01% Equity stake in RPPL in one or more tranches for a consideration of Rs 7.00 crore.

The said partnership with RPPL would benefit the company in co-developing, marketing and sourcing key Active Pharma Ingredients (APIs) and Speciality Chemicals products. Also, this partnership will help the Company to set its footprints in various Geographic areas. 

Reflux Pharmaceuticals is a private limited company involved in the manufacturing and marketing of its own Active Pharmaceutical ingredients and Intermediates (APIs). The various products manufactured by RPPL are Tolfenamic Acid, Flavoxate HCI, Diacerein, Albendazole, Carprofen, Sulindac etc.

Eiko LifeSciences is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and Globally.


Eiko Lifesciences Share Price

61.74 -0.83 (-1.33%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1046.80
SRF 2259.95
Pidilite Inds. 2911.00
Aarti Inds 411.35
Atul 7062.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.